As of Aug 27
| +0.0101 / +1.98%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 0.96, with a high estimate of 0.96 and a low estimate of 0.96. The median estimate represents a +84.58% increase from the last price of 0.52.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.